BRCA1 and neoplasm: Finally, we investigated the prevalence of germline pathogenic variants in non-BRCA1/2 HRR-associated genes in women diagnosed with non-mucinous high-grade EOC aged ≥80 who also underwent tumour testing using Myriad’s myChoice® CDx.